logo

(877) 920-9009
ABSOLUTELY NO COST TO YOU UNLESS WE WIN

Jury Orders Johnson & Johnson to Pay $27.8 Million in Xarelto Lawsuit

Posted on behalf of Stephens, Anderson & Cummings on Dec 26, 2017 in Dangerous Drugs

prescription pad and judge gavelA Philadelphia state court ordered Johnson & Johnson and Bayer AG to pay $27.8 million to an Indiana couple for failing to warn victims of bleeding risks associated with the anticoagulant Xarelto.

The recent court ruling marks the first courtroom victory involving Xarelto. The 75-year-old victim was awarded $1.8 million in compensatory damages and $26 million in punitive damages. Three other Xarelto lawsuits have gone to trial, but juries ruled in favor of Johnson & Johnson and Bayer AG.   

The Fort Worth defective drug lawyers of Stephens, Anderson & Cummings are here to assist you if you have suffered an injury caused by Xarelto. Contact us to schedule a free, no obligation consultation to find out if you may be entitled to file a Xarelto lawsuit to pursue compensation.

Internal Bleeding Caused by Xarelto, Says Victim

The most recent Xarelto lawsuit was filed by a 75-year-old woman who was prescribed Xarelto to prevent strokes as a result of an irregular heartbeat. However, the victim was hospitalized in June 2014 for gastrointestinal bleeding, approximately one year after being prescribed the drug. 

The victim underwent four blood transfusions as a result of the bleeding that she claims was caused by taking Xarelto. Since the victim has been taken off Xarelto, she claims to have not suffered a bleeding event.

The victim’s lawsuit alleges that Xarelto’s manufacturers, Johnson & Johnson and Bayer AG, did not properly warn doctors and patients of the risk of bleeding connected to the drug. Additionally, Xarelto’s labeling understated its risks, and physicians were not warned that certain patients have a higher risk of bleeding.

Currently, there are more than 20,000 Xarelto lawsuits pending against Johnson & Johnson and Bayer AG. Johnson & Johnson and Bayer AG have since announced their plans to appeal to appeal the decision.

Dangers Linked to Xarelto

Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011 for treating atrial fibrillation. Xarelto is also prescribed to lower risks linked to deep vein thrombosis and pulmonary embolism.

The drug was marketed as a superior anticoagulant to Warfarin, a popular blood thinner prescribed for decades with proven success. Xarelto’s manufacturers claimed the drug was a better option because it does not require patients to follow dietary requirements or undergo frequent dosage adjustments.

Although uncontrollable bleeding is a common side effect caused by anticoagulants, it can often be stopped by an antidote. However, there is no antidote to stop bleeding caused by Xarelto. Many lawsuits claim this makes Xarelto defective and unreasonably dangerous.

Additionally, the FDA has linked at least 370 deaths to Xarelto, caused by fatal blood clots and thromboembolism that form after taking the drug.

Despite the adverse health effects associated with Xarelto, the blood thinner has generated $2.2 billion in revenue for Johnson & Johnson and $3.41 billion in revenue for Bayer AG in 2016.

Contact Our Defective Drug Lawyers Now

If you suffered complications after taking Xarelto, you may be able to file a Xarelto lawsuit for compensation for your medical bills, lost wages, and pain and suffering.

Schedule a free, no obligation consultation with our attorneys to learn the legal options that may be available to you. Our personal injury lawyers work on contingency fee basis and provide our services at no upfront cost. We will only charge you legal fees if we recover compensation for your claim.

Call (877) 920-9009 or complete our Free Case Evaluation form now.